Jason Gross
Technik-/Wissenschafts-/F&E-Leiter bei HLS THERAPEUTICS INC.
Vermögen: 29 011 $ am 30.04.2024
Aktive Positionen von Jason Gross
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| HLS THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2014 | - |
Karriereverlauf von Jason Gross
Ehemalige bekannte Positionen von Jason Gross
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Private Equity Investor | - | 31.03.2006 |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology HLS Therapeutics, Inc. provides specialty pharmaceutical products. It focuses on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company was founded by William McDowall Wells, Gregory Gubitz, Gilbert Godin and Joseph Anthony MacLean and is headquartered in Etobicoke, Canada. | Corporate Officer/Principal | - | - |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Drugabuse Sciences, Inc. | General Counsel | - | - |
| CIPHER PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 16.06.2006 | - |
Ausbildung von Jason Gross
| University of Arizona | Doctorate Degree |
Statistik
International
| Kanada | 5 |
| Vereinigte Staaten | 4 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Private Equity Investor | 1 |
| General Counsel | 1 |
Sektoral
| Health Technology | 5 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| CIPHER PHARMACEUTICALS INC. | Health Technology |
| HLS THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Finance |
| Drugabuse Sciences, Inc. | |
IVAX Pharmaceuticals, Inc.
IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Health Technology |
HLS Therapeutics, Inc. /Old/
HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology HLS Therapeutics, Inc. provides specialty pharmaceutical products. It focuses on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company was founded by William McDowall Wells, Gregory Gubitz, Gilbert Godin and Joseph Anthony MacLean and is headquartered in Etobicoke, Canada. | Health Technology |
- Börse
- Insiders
- Jason Gross
- Erfahrung
